A phase II study of STEALTH cisplatin (SPI-77) in patients with advanced non-small cell lung cancer
- 1 December 2001
- journal article
- clinical trial
- Published by Elsevier in Lung Cancer
- Vol. 34 (3) , 427-432
- https://doi.org/10.1016/s0169-5002(01)00278-1
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- A Phase I Study of STEALTH® Cisplatin (SPI-77) and Vinorelbine in Patients with Advanced Non–Small-Cell Lung CancerClinical Lung Cancer, 2000
- Randomized Phase III Trial of Docetaxel Versus Vinorelbine or Ifosfamide in Patients With Advanced Non–Small-Cell Lung Cancer Previously Treated With Platinum-Containing Chemotherapy RegimensJournal of Clinical Oncology, 2000
- Prospective Randomized Trial of Docetaxel Versus Best Supportive Care in Patients With Non–Small-Cell Lung Cancer Previously Treated With Platinum-Based ChemotherapyJournal of Clinical Oncology, 2000
- Phase II study of liposomal doxorubicin in refractory ovarian cancer: antitumor activity and toxicity modification by liposomal encapsulation.Journal of Clinical Oncology, 1997
- Efficacy of pegylated-liposomal doxorubicin in the treatment of AIDS-related Kaposi's sarcoma after failure of standard chemotherapy.Journal of Clinical Oncology, 1997
- Phase II study of docetaxel for advanced or metastatic platinum-refractory non-small-cell lung cancer.Journal of Clinical Oncology, 1995
- Light microscopic localization of silver-enhanced liposome-entrapped colloidal gold in mouse tissuesBiochimica et Biophysica Acta (BBA) - Biomembranes, 1991
- Clinical Pharmacokinetics of CarboplatinClinical Pharmacokinetics, 1991
- CarboplatinDrugs, 1989